Hybrid robotic mitral valve surgery with staged percutaneous coronary intervention for degenerative mitral regurgitation and coronary artery disease

For patients with degenerative mitral valve regurgitation and coronary artery disease, a hybrid approach (robotic mitral valve surgery + percutaneous coronary intervention) provided enhanced postoperative outcomes with short- and mid-term survival comparable to the conventional operation (sternotomy mitral valve surgery + coronary artery bypass grafting).